Who
Justin Trojanowski
Corporate Controller
Company insider
Files Form 4 as: Corporate Controller, Tempest Therapeutics.
In numbers
- Trades disclosed
- 8
- Buys
- 1
- Sells
- 0
- Bought
- $16K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 3 Oct 2022
- Last trade
- 31 Mar 2026
- Last filed
- 2 Apr 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 31 Mar 2026filed 2 Apr 2026 | TPST Tempest Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,000 at $0.00 | filing |
| 31 Mar 2026filed 2 Apr 2026 | TPST Tempest Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,000 at $0.00 | filing |
| 2 Jan 2025filed 6 Jan 2025 | TPST Tempest Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 28 Jun 2024filed 2 Jul 2024 | TPST Tempest TherapeuticsBiotechnology | SEC FORM 4 Bought | $16K7,500 at $2.16 | filing |
| 3 Jan 2024filed 5 Jan 2024 | TPST Tempest Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —26,500 at $0.00 | filing |
| 11 Oct 2023filed 13 Oct 2023 | TPST Tempest Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —55,000 at $0.00 | filing |
| 3 Jan 2023filed 5 Jan 2023 | TPST Tempest Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,300 at $0.00 | filing |
| 3 Oct 2022filed 4 Oct 2022 | TPST Tempest Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,500 at $0.00 | filing |
News
Tempest Therapeutics, Inc. (NASDAQ:TPST) Shares Shorted: Short Interest Up 73.6% in SeptemberTPST · dailypolitical.com · 17 Oct 2026Tempest Therapeutics (NASDAQ:TPST) Upgraded to "Sell" at Wall Street ZenTPST · dailypolitical.com · 11 Oct 2026
0 headlines in the last 90 days name Justin Trojanowski; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.